Black, Hispanic Patients Less Likely to Get Outpatient COVID-19 Treatment

Black and Hispanic patients are less likely to receive outpatient COVID-19 treatment. Electronic health record data showed the percentage of adults treated with nirmatrelvir/ritonavir (Paxlovid, Pfizer) was 35.8% and 29.9% lower among Black and Hispanic patients vs. White and non-Hispanic patients.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ